Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)

NCT02320396 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

449

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG: Desloratadine 5 mg
DRUG: Placebo

Sponsor

Organon and Co